West Tower Group’s Chemours CC Stock Holding History

West Tower Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-123	Closed	-$3.88K	–	158
2023 Q4	$3.88K	Buy	+123	New	+$3.34K	0.01%	457

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

West Tower Group's CC Position: Q1 2024 in Review

West Tower Group sold out of Chemours (CC) in Q1 2024, closing a stake of 123 shares — an estimated $3.88K sold.

West Tower Group first reported a position in CC in Q4 2023 and held it in 1 quarter. The position peaked at $3.88K in Q4 2023. 443 funds tracked by Wall St. Rank hold CC as of Q1 2024.

West Tower Group reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
West Tower Group sold 123 Chemours shares in Q1 2024, an estimated $3.88K.
West Tower Group first reported a position in Chemours in Q4 2023 and held it in 1 quarter.
West Tower Group's Chemours position peaked at $3.88K in Q4 2023.
443 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.